作者: Larissa V. Furtado , Wade S. Samowitz
DOI: 10.1007/S00428-017-2153-8
关键词:
摘要: Advances in defining the mutational landscape of colorectal cancer (CRC) over past decades have revolutionized molecular understanding and clinical testing algorithms for this disease. Mutation is standard care work-up CRCs. This review focuses on current indications strategies CRC discusses potential changes approach associated with emerging application genomic-based technologies.